Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 2, 2000, Pages 137-150

  Radewicz, Katrina ^a   Garey, Laurence J ^a   Gentleman, Stephen M ^a   Reynolds, Richard ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Astroglia; Cerebral cortex; Glia; Immunohistochemistry; Microgila; Schizophrenia

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; HLA SYSTEM; HUMAN; HUMAN TISSUE; MICROGLIA; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0033983020     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.2.137     Document Type: Article

References (56)

1. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-69
2. Ross CA, Pearlson GD. Schizophrenia, the heteromodal association neocortex and development: potential for a neurogenetic approach. Trends in Neurosci 1996;19:171 76
3. Harrison PJ. On the neuropathology of schizophrenia and its dementia: Neurodevelopmental, neurodegenerative, or both? Neurodegeneration 1995;4:1-12
4. Harrison PJ. Schizophrenia: A disorder of neurodevelopment. Current Opinion in Neurobiology 1997;7:285-89
5. Walker EF, Savoie T, Davis D. Neuromotor precursors of schizophrenia. Schizophr Bull 1994;20:441-51
6. Jones S. Tallis F. What is schizophrenia? In: Coping with schizophrenia. London: Sheldon Press, 1994
7. Done DJ, Crow TJ, Johnstone EC, Sacker A. Childhood antecedents of schizophrenia and affective illness: social adjustments at ages 7 and 11. Brit Med J 1994;309:699-703
8. Frangou S, Murray RM. Imaging as a tool in exploring the neurodevelopment and genetics of schizophrenia. Br. Med. Bull. 1996;52:587-96
9. DeLisi LE, Tew W, Xie et al. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol Psychiatry 1995;38:349-60
10. DeLisi LE, Sakuma M, Tew W, Kushner M, Hoff AL, Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res 1997;74:129-40
11. DeLisi LE, Ge S, Sakuma M, Crimson R, Kushner M, Hoff AL. The progression of brain structural changes in schizophrenia: Update on clinical/cognitive significance and its underlying basis. Schizophr Res 1998;29:76
12. Nair TR, Christensen JD, Kingsbury J, Kumar NG, Terry WM, Garver DL. Progression of cerebroventricular enlargement and the subtyping of schizophrenia. Psychiatry Res 1997;74:141-50
13. DeLisi LE. Is schizophrenia a lifetime disorder of brain plasticity, growth and aging? Schizophr Res 1997;23:119-29
14. Eastwood SL, Burnet WJ, Harrison PJ. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 1995;66:309-19
15. Garey LJ, Ong WY, Patel TS, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg & Psych 1998;65:446-53
16. Miyakawa T, Sumiyoshi S, Deshimaru M, et al. Electron microscopic study on schizophrenia. Mechanism of pathological changes. Acta Neuropathol 1972;20:67-77
17. Uranova NA, Orlovskaya DD, Kolomeets S, Vikhreva OV, Zimina IS, Denisov DV. Morphometric study of synaptic size in autopsied prefrontal cortex, caudate nucleus and substantia nigra. Schizophr Bull 1997;24:41
18. Uranova NA, Vikhreva OV, Orlovskaya DD, Denisov DV. Increased numerical density of synapses in layer VI of postmortem prefrontal cortex in schizophrenia. Schizophr Bull 1998;29:86
19. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 1991;48:996-1001
20. Davis SR, Lewis DA. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res 1995;59:81-96
21. Akbarian S, Kim JJ, Potkin SG, Hetrick WP, Bunney W, Jones EG. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. Arch Gen Psychiatr 1996;53: 425-36
22. Beasley CL, Reynolds GP. Parvalbumin immunoreactive neurones are reduced in the pre-frontal cortex of schizophrenics. Schizophr Res 1997;24:349-55
23. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990;47:1023-28
24. Averback P. Structural lesions of the brain in young schizophrenics. Can J Neurol Sci 1981;8:73-76
25. Roberts RC, Conley R, Kung L, Peretti FJ, Chute DJ. Reduced striatal spine size in schizophrenia: A post-mortem ultrastructural study. NeuroReport 1996;26:1214-18
26. Glantz LA, Lewis DA. Specificity of decreased spine density on layer III pyramidal cells in schizophrenia. Soc Neurosci Abs 1996;22:1679
27. Selemon LD, Rajkowska G, Goldman-Rakic PS. Abnormally high neuronal density in the schizophrenic cortex. Arch Gen Psychiatry 1995;52:805-18
28. Falkai P, Bogerts B, Rozumek M. Limbic pathology in schizophrenia: The entorhinal region - a morphometric study. Biol Psychiatry 1988;24:515-21
29. Casanova MF. Stevens JR, Kleinman JE. Astrocytosis in the molecular layer of the dentate gyrus: A study in Alzheimer's disease and schizophrenia. Psychiatry Res 1990;35:149-66
30. Stevens JR, Casanova MF, Bigelow L. Gliosis and schizophrenia. Biol Psychiatry 1988;24:727-29
31. Roberts GW, Colter N, Lofthouse R. Johnstone EC, Crow TJ. Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry 1987;22:1459-68
32. Mirra SS, Heyman A, McKeel D, et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of AD. Neurology 1991;41: 479-86
33. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer's disease. J Neuroimmunol 1989;24:173-82
34. Carpenter AF, Carpenter PW, Markesbery WR. Morphometric analysis of microglia in Alzheimer's disease. J Neuropathol Exp Neurol 1993;52:601-8
35. Rogers J, Luber-Narod J, Styren SD, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to pathology of Alzheimer's disease. Neurobiol Aging 1988;9:339-49
36. Mattiace LA, Davies P, Dickson DW. Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. Am J Pathol 1990;136:1101-14
37. Styren SD, Civin WH, Rogers J. Molecular, cellular and pathologic characterization of HLA-DR immunoreactivity in normal elderly and Alzheimer's disease brain. Exp Neurol 1990;110:93-104
38. Streit WJ. The role of microglia in brain injury. NeuroToxicol 1996;17:671-78
39. Gehrmann J, Matsumoto Y, Kreutzberg GW. Microglia: intrinsic immuneffector cell of the brain. Brain Res Rev 1995;20:269-87
40. Perlmutter LS, Scott SA, Barren E, Chui HC. MHC class II-positive microglia in human brain: association with Alzheimer's lesions. J Neurosci Res 1992;33:549-58
41. Gehrmann J, Banati RB, Kreutzberg GW. Microglia in the immune surveillance of the brain: human microglia constitutively express HLA-DR molecules. J Neuroimmunol 1993;48:189-98
42. Kreuzberg GW. Microglia: A sensor for pathological events in the CNS. Trends in Neurosci 1996;19:312-18
43. Selemon LD, Lidow MS, Goldman-Rakic PS. Chronic neuroleptic drug treatment induces mild gliosis in the prefrontal cortex of rhesus monkeys. Schizophr Research 1997;24:266
44. Kimelberg HK. Receptors on astrocytes-what possible functions? Neurochem Int 1995;26:27-40
45. Haas S, Brockhaus J, Verkhratsky A, Kettenmann, H. ATP-induced membrane currents in amoeboid microglia acutely isolated from mouse brain slices. Neuroscience 1996;75:257-61
46. Wilson MA, Moliver ME. Microglial responses to degeneration of serotonergic axon terminals. Glia 1994;11:18-34
47. Graeber MB, Bise K, Mehraein P. Synaptic stripping in the human facial nucleus. Acta Neuropathol 1993;86:179-81
48. Heresco-Levy U, Silipo G, Javitt DC. Glycinergic augmentation of NMDA receptor-mediated neurotransmission of schizophrenia. Psychopharmacol Bull 1996;32:731-40
49. Heyes MP, Achim CL, Wiley CA, Major EO, Saito K, Markey SP. Human microglia convert l-tryptophan into the neurotoxin quinolinic acid. Biochem J 1996;320:595-97
50. Acarin L, Gonzalez B, Castellano B, Castro AJ. Microglial response to N-methyl-D-aspartate-mediated excitotoxicity in the immature rat brain. J Comp Neurol 1996;367:361-74
51. Yoshioka M, Bradley WG, Shapshak P, et al. Role of immune activation and cytokine expression in HIV-1 associated neurologic diseases. Adv Neuroimmunol 1995;5:335-58
52. Gehrmann J, Banati RB, Wiessner C, Hossman KA, Kreutzberg GW. Reactive microglia in cerebral ischaemia: An early mediator of tissue damage? Neuropathol Appl Neurobiol 1995;21:227-89
53. Gehrmann J, Banati RB. Microglial turnover in the injured CNS: Activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J Neuropathol Exp Neurol 1995;54:680-88
54. Morioka T, Kalehua AN, Streit WJ. Characterization of microglial reaction after middle cerebral artery occlusion in rat brain. J Comp Neurol 1993;327:123-32
55. Arnold SE, Franz BR, Trojanowski JQ, Moberg PJ, Gur RE. Glial fibrillary acidic protein-immunoreactive astrocytosis in elderly patients with schizophrenia and dementia. Acta Neuropathol 1996;91: 269-77
56. Ong WY, Garey LJ, Reynolds R. Distribution of glial fibrillary acidic protein and glutamine synthetase in human cerebral cortical astrocytes-a light and electron microscopic study. J Neurocytol 1993;22:893-902